Kaplan v. University of Louisville

CourtDistrict Court, W.D. Kentucky
DecidedJuly 24, 2020
Docket3:19-cv-00825
StatusUnknown

This text of Kaplan v. University of Louisville (Kaplan v. University of Louisville) is published on Counsel Stack Legal Research, covering District Court, W.D. Kentucky primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Kaplan v. University of Louisville, (W.D. Ky. 2020).

Opinion

UNITED STATES DISTRICT COURT WESTERN DISTRICT OF KENTUCKY AT LOUISVILLE

HENRY KAPLAN, M.D. PLAINTIFF

vs. CIVIL ACTION NO. 3:19-CV-825-CRS

UNIVERSITY OF LOUISVILLE et al. DEFENDANTS

MEMORNADUM OPINION

I. Introduction

This matter is before the Court on Defendants University of Louisville (the “University”), Dr. Toni Ganzel (“Dean Ganzel”), Dr. Ronald Paul (“Dr. Paul”), and Dr. Gregory Postel’s (“Dr. Postel”), motion to dismiss. DN 16. The Plaintiff, Dr. Henry Kaplan (“Dr. Kaplan”), has responded and the Defendants replied. DN 19; DN 21. The matter is now ripe for review. For the following reasons, the Court will grant Defendants’ motion to dismiss. II. Factual Background

This case arises from an investigation into Dr. Kaplan’s actions as Chair of the Department of Ophthalmology and Visual Sciences (“DOVS”) at the University’s School of Medicine. Dr. Kaplan was a tenured professor at the University and had served as the DOVS’ Chair since 2000. DN 15 at ¶ 29. Dr. Kaplan’s most recent five-year term as department Chair was anticipated to run from 2017 to 2022. Id. at ¶ 36. According to Dr. Kaplan’s amended complaint, in May of 2018, the University announced cost control measures for the 2019 fiscal year that would directly affect the DOVS. Id. at ¶ 37. In response to these measures, Dr. Kaplan began to research alternative revenue sources. Id. at ¶ 40. One such revenue source “widely known to be available in the medical field of ophthalmology,” Dr. Kaplan alleges, would have been for the DOVS to sell its clinical practice to a private equity group. Id. at ¶ 41. In researching this potential revenue source, Dr. Kaplan “had detailed communications with four investments groups” regarding a potential purchase of the DOVS’ clinical practice. Id. at ¶ 45. At approximately the same time, Dr. Kaplan alleges that he began to inquire about leasing a new workspace for the DOVS’ clinical practice, University of Louisville Physicians-Eye

Specialists (“ULP”). Id. at ¶ 49. Dr. Kaplan states that he asked ULP’s CEO whether the DOVS could lease more office space in the ULP’s current location, the Springs Medical Center located at 6400 Dutchmans Parkway in Louisville. Id. at ¶ 48–50. ULP’s CEO informed him that there was no office space available. Id. at ¶ 50. Despite being told that no office space was available, Dr. Kaplan “began working to secure a lease at [the Springs Medical Center]” for more office space. Id. at ¶ 52. On May 21, 2018, Dr. Kaplan signed a lease for the new space because “it was in the best interest of the Department.” Id. at ¶ 54. On October 16, 2018, Dr. Kaplan met with Dr. Ganzel, Dean of the School of Medicine, and Dr. Postel, the University’s interim Executive Vice President. Id. at ¶ 57; DN 15-4. Both Dean

Ganzel and Dr. Postel had received “several concerns” about Dr. Kaplan’s “actions as Chair of the Department of Ophthalmology and Visual Sciences.” DN 15-4 at 1. According to the letter from Dean Ganzel to Dr. Kaplan, they discussed the following: [W]e discussed your unauthorized execution of a lease on behalf of ULP, failure to honor your initial obligation of the Department to occupy space and use equipment in the PMOB resulting in expense to re-stock equipment, alleged attempt to seek a loan to fund operations outside of ULP’s regular financing that could compromise ULP’s debt covenant agreement and the creation of an LLC, that if intended to spin- off the clinical practice of the Department into an outside entity, would violate the Practice Plan.

Id. Dean Ganzel further stated in the letter that “these actions, if true, range from insubordination and acting outside the scope of your authority as Chair to a potential violation of the Professional Practice Plan and conflict of interest.” Id. Based on these allegations, Dean Ganzel instituted a “special chair review” pursuant to § 3.3.5.D.3 of the University’s Redbook1 to “ensure a full and fair investigation of these actions and allegations.” Id. On November 15, 2018, Dr. Kaplan met with Dean Ganzel and Dr. Ron Paul, Vice-Dean for Faculty Affairs. DN 15 at ¶ 61–62; DN 15-5. Dean Ganzel informed Dr. Kaplan via email that

the “Special Chair Review, which commenced in late October, ha[d] ceased and any investigation into the allegations brought to the attention of University officials will continue to be investigated by Compliance and Audit Services.” DN 15-5 at 1. Further, Dean Ganzel told Dr. Kaplan that he would be placed on administrative leave with pay immediately and the investigation could result in “disciplinary action, up to and including termination as Chair and/or as a faculty member.” Id. As part of his administrative leave, the University prohibited Dr. Kaplan from engaging “in any activity on behalf of the University, including in [his] role as chair, faculty member or physician.” Id. Dr. Kaplan claims that the administrative leave effectively made him “persona non grata (“PNG”) at the University indefinitely.” DN 15 at ¶ 65. He further alleges that he suffered

several “negative ramifications” as a result of being placed on administrative leave. Id. at ¶ 70. First, he alleges that the administrative leave “eliminated [his] ability to treat any of his patients” which affected his patients’ care and his “professional standing and reputation.” Id. at ¶ 71–76. Second, he alleges that the administrative leave “interfered” with several “then-current, awarded grant projects.” Id. at ¶ 77–92. He further alleges that “the University, through its agents, employees, and representatives, have informed faculty with whom Dr. Kaplan collaborated not to include his name on any manuscripts or grants.” Id. at ¶ 86.

1 “The Redbook of the University of Louisville is the basic governance document of the University.” http://louisville.edu/provost/redbook. Dr. Kaplan’s amended complaint incorporates the entire Redbook by reference. DN 15 at p. 26, fn. 3. Third, Dr. Kaplan alleges that the administrative leave adversely impacted his professional reputation. Id. at ¶ 93–100. Specifically, Dr. Kaplan alleges the University, through its agents, employees, and representatives, made four statements that “compounded the negative impact on Dr. Kaplan’s professional standing, character, reputation, and integrity”: (1) the University told resident candidates that Dr. Kaplan was on administrative leave, id. at ¶ 96, (2) the University told

the American University Professors of Ophthalmology that Dr. Kaplan was no longer Department Chair prior to his actual removal as Chair, id. at ¶ 97, (3) the University contacted the National Eye Institute and informed the organization that Dr. Kaplan was under investigation, id. at 98, and (4) the University represented to the Louisville Lions Club that Dr. Kaplan had been replaced as Department Chair, id. at 99. As part of the investigation, Dr. Kaplan met with Audit Services on February 28, 2019. Id. at ¶ 106. Audit Services then issued its investigation Report on April 19, 2019. Id. at ¶ 96. DN 15- 11. The Report ultimately substantiated the allegations against Dr. Kaplan that were outlined by Dean Ganzel during the October 16 meeting, and “identified additional issues” related to Dr.

Kaplan’s conduct as Department Chair. DN 15-11 at 2. These additional issues included “a HIPAA violation; a violation of the University’s conflicts of interest policy; accusations of improperly treating Department administrative staff; and Department financial mismanagement.” DN 15 at ¶ 110. Dr. Kaplan claims that these issues were “unnoticed allegations.” Id. The report recommended that the administration “take appropriate disciplinary action, up to and including termination of Dr. Kaplan’s position as Chair of the DOVS and revocation of tenure at the University of Louisville.” DN 15-11 at 2. Dr.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Ex Parte Young
209 U.S. 123 (Supreme Court, 1908)
Meyer v. Nebraska
262 U.S. 390 (Supreme Court, 1923)
Board of Regents of State Colleges v. Roth
408 U.S. 564 (Supreme Court, 1972)
Perry v. Sindermann
408 U.S. 593 (Supreme Court, 1972)
Paul v. Davis
424 U.S. 693 (Supreme Court, 1976)
Pennhurst State School and Hospital v. Halderman
465 U.S. 89 (Supreme Court, 1984)
Cleveland Board of Education v. Loudermill
470 U.S. 532 (Supreme Court, 1985)
Regents of the University of Michigan v. Ewing
474 U.S. 214 (Supreme Court, 1985)
Seminole Tribe of Florida v. Florida
517 U.S. 44 (Supreme Court, 1996)
Gilbert v. Homar
520 U.S. 924 (Supreme Court, 1997)
Swierkiewicz v. Sorema N. A.
534 U.S. 506 (Supreme Court, 2002)
Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)
Ashcroft v. Iqbal
556 U.S. 662 (Supreme Court, 2009)
Thiokol Corporation v. Department Of Treasury
987 F.2d 376 (Sixth Circuit, 1993)

Cite This Page — Counsel Stack

Bluebook (online)
Kaplan v. University of Louisville, Counsel Stack Legal Research, https://law.counselstack.com/opinion/kaplan-v-university-of-louisville-kywd-2020.